학술논문
Clinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancer
Document Type
Article
Author
Sharma, P.; O’Dea, A.; Nye, L.; Hoffmann, M.; Elia, M.; Schwensen, K.; Williamson, S.K.; Khan, Q.J.; Abramson, V.G.; Mayer, I.; Pathak, H.B.; Godwin, A.K.; Stecklein, S.R.; Kimler, B.F.; Lewis, S.; Scott, J.; de Jong, J.A.; Wang, Y.Y.; Yoder, R.; Finke, K.; Heldstab, J.; LaFaver, S.; Reed, G.A.; Phadnis, M.A.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 July 2021, 27(14):3896-3904)
Subject
Language
English
ISSN
15573265
10780432
10780432